ecrin-mdr-crcClinical2018Gastric CancerColorectal CancerEsophageal CancerCholangiocarcinomaHepatocellular CarcinomaGastric CancerColorectal CancerEsophageal CancerCholangiocarcinomaHepatocellular CarcinomaInterventionalhttps://newmdr.ecrin.org/Study/2289040China11ECRIN MDRNot providedfalseA Phase 1 Study of ZSP1241 in Participants With Advanced Solid TumorsThe purpose of this study is to evaluate the safety, tolerability and pharmacokinetics, and determine the maximum tolerated dose of ZSP1241 in participants with hepatocellular carcinoma, cholangiocarcinoma, gastric cancer, esophageal cancer, colorectal cancer and other advanced solid tumors.2018-11-152289040NCT03734926